Sun Pharma shares tumble over 4% post Q4 earnings
indiatimes.com
business
2022-05-31 07:00:00

NEW DELHI: Shares of Sun Pharmaceutical Industries fell by over 4 per cent in morning trade on Tuesday a day after the company said its consolidated net loss stood at Rs 2,277 crore for the fourth quarter ended March 2022, mainly on account of a one-time exceptional loss. The company's stock declined 4.12 per cent to Rs 851.50 on the BSE.At the NSE, it tumbled 4.17 per cent to Rs 851.20 apiece.The Mumbai-based drug major on Monday reported a net profit of Rs 894 crore in the January-March period of 2020-21.
